SEC Form SC 13D/A filed by SKYX Platforms Corp. (Amendment)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
SKYX PLATFORMS CORP.
(Name of Issuer)
Common Stock, no par value per share
(Title of Class of Securities)
78471E105
(CUSIP Number)
Rani Kohen
c/o SKYX Platforms Corp.
2855 W. McNab Road
Pompano Beach, Florida 33069
(855) 759-7584
With a copy to:
Jurgita Ashley
Thompson Hine LLP
3900 Key Center
127 Public Square
Cleveland, Ohio 44114
(216) 566-5500
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 14, 2024
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 78471E105 | 13D | Page 2 of 4 Pages |
| 1 | NAME OF REPORTING PERSON
Rani R. Kohen |
|
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐ (b) ☐ |
| 3 | SEC USE ONLY
|
|
| 4 | SOURCE OF FUNDS
PF; AF; OO |
|
| 5 | CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
|
☐ |
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER
9,259,970(1) |
| 8 | SHARED VOTING POWER
0 | |
| 9 | SOLE DISPOSITIVE POWER
15,199,970(1)(2) | |
| 10 | SHARED DISPOSITIVE POWER
0 |
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
15,199,970(1)(2) |
|
| 12 | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
☐ |
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.3% |
|
| 14 | TYPE OF REPORTING PERSON
IN |
| (1) | Includes (i) 9,143,969 shares of Common Stock held by KRNB Holdings, LLC, of which Mr. Kohen is the sole owner and manager, and (ii) 100,000 shares of Common Stock held by a family member. |
| (2) | Includes 5,940,000 shares of Common Stock that may be acquired pursuant to the exercise of stock options that are exercisable within 60 days of the filing of this Statement. |
| CUSIP No. 78471E105 | 13D | Page 3 of 4 Pages |
This Amendment No. 2 to Statement of Beneficial Ownership on Schedule 13D (this “Amendment No. 2”) amends the Statement of Beneficial Ownership on Schedule 13D filed by Rani Kohen on February 15, 2022 (as amended, the “Schedule 13D” or this “Statement”). Capitalized terms used but not defined in this Amendment No. 2 shall have the meanings set forth in the Schedule 13D. Except as amended and supplemented by this Amendment No. 2, the Schedule 13D remains unchanged.
This Amendment No. 2 is being filed to reflect the change in percentage of beneficial ownership held by Mr. Kohen as a result of a change in outstanding shares of Common Stock of the Company.
Item
5. Interest in Securities of the Issuer.
| (a) | Mr. Kohen beneficially owns in the aggregate 9,259,970 shares of Common Stock, which represents approximately 9.3% of the Company’s outstanding shares of Common Stock and includes 9,143,969 shares of Common Stock directly held by KRNB Holdings, LLC, which Mr. Kohen, as the sole owner and manager of KRNB Holdings, LLC, may be deemed to beneficially own, and 100,000 shares of Common Stock held by a family member. |
Mr. Kohen also holds options to purchase an aggregate of 5,940,000 shares of Common Stock that are exercisable within 60 days of the date of this Statement and were received as part of his executive officer compensation. Such options include (i) options to purchase 1,000,000 shares of Common Stock at an exercise price of $0.60 per share, which were granted on November 15, 2015 and expire on November 15, 2025; (ii) options to purchase 1,140,000 shares of Common Stock at an exercise price of $6.00 per share, all of which are currently exercisable, which were granted on September 1, 2019 and expire on September 1, 2024; (iii) options to purchase 1,140,000 shares of Common Stock at an exercise price of $12.00 per share, 800,000 of which are currently exercisable, which were granted on January 1, 2022 and expire on January 1, 2027; and (iv) options to purchase 3,000,000 shares of Common Stock at an exercise price of $3.00 per share for 1,500,000 shares, $4.00 per share for 500,000 shares, and $6.00 per share for 1,000,000 shares, which were granted on November 21, 2019 and expire on November 21, 2024. In addition, Mr. Kohen also holds performance-based options to purchase 17,000,000 shares of Common Stock at exercise prices ranging from $4.00 to $12.00 per share that are not exercisable within 60 days of the date of this Statement.
Each percentage ownership of Common Stock set forth in this Statement is based on the 100,032,804 shares of Common Stock reported by the Company as outstanding as of May 1, 2024 in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 filed with the Securities and Exchange Commission on May 14, 2024.
| (c) | No transactions in the Common Stock have been effected by Mr. Kohen during the past 60 days. |
| CUSIP No. 78471E105 | 13D | Page 4 of 4 Pages |
SIGNATURE
After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
Dated: May 16, 2024
| /s/ Rani R. Kohen | |
| RANI R. KOHEN |